Department of Nutrition, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43300, Serdang, Malaysia.
Charles Perkins Centre, Faculty of Medicine and Health Sciences, The University of Sydney, Sydney, NSW, Australia.
J Bone Miner Metab. 2024 May;42(3):290-301. doi: 10.1007/s00774-024-01512-8. Epub 2024 May 25.
Osteoporosis is a significant health concern characterized by weak and porous bones, particularly affecting menopausal women aged 50 and above, leading to increased risk of hip fractures and associated morbidity and mortality.
We conducted a study to assess the efficacy of single-strain versus mixed-strain probiotic supplementation on bone health using an ovariectomy (OVX) rat model of induced bone loss. The probiotics evaluated were Lactobacillus helveticus (L. helveticus), Bifidobacterium longum (B. longum), and a combination of both. Rats were divided into five groups: SHAM (Control negative), OVX (Control positive), OVX +L. helveticus, OVX + B. longum, and OVX + mixed L. helveticus and B. longum. Daily oral administration of probiotics at 10^8-10^9 CFU/mL began two weeks post-surgery and continued for 16 weeks.
Both single-strain and mixed-strain probiotic supplementation upregulated expression of osteoblastic genes (BMP- 2, RUNX-2, OSX), increased serum osteocalcin (OC) levels, and improved bone formation parameters. Serum C-terminal telopeptide (CTX) levels and bone resorption parameters were reduced. However, the single-strain supplementation demonstrated superior efficacy compared to the mixed-strain approach.
Supplementation with B. longum and L. helveticus significantly reduces bone resorption and improves bone health in OVX rats, with single-strain supplementation showing greater efficacy compared to a mixed-strain combination. These findings highlight the potential of probiotics as a therapeutic intervention for osteoporosis, warranting further investigation in human studies.
骨质疏松症是一种严重的健康问题,其特征是骨骼脆弱多孔,尤其影响 50 岁及以上的绝经后妇女,增加髋部骨折的风险,并导致相关发病率和死亡率增加。
我们进行了一项研究,使用去卵巢(OVX)诱导骨质流失大鼠模型,评估单一菌株与混合菌株益生菌补充对骨骼健康的功效。评估的益生菌为瑞士乳杆菌(L. helveticus)、长双歧杆菌(B. longum)以及两者的组合。大鼠分为五组:SHAM(阴性对照)、OVX(阳性对照)、OVX+L. helveticus、OVX+B. longum 和 OVX+混合 L. helveticus 和 B. longum。益生菌以 10^8-10^9 CFU/mL 的剂量每天口服给药,在手术后两周开始,并持续 16 周。
单一菌株和混合菌株益生菌补充均上调成骨基因(BMP-2、RUNX-2、OSX)的表达,增加血清骨钙素(OC)水平,并改善骨形成参数。血清 C 端肽(CTX)水平和骨吸收参数降低。然而,单一菌株补充的效果优于混合菌株补充。
B. longum 和 L. helveticus 的补充显著减少 OVX 大鼠的骨吸收并改善骨骼健康,与混合菌株组合相比,单一菌株补充具有更高的功效。这些发现强调了益生菌作为骨质疏松症治疗干预的潜力,值得在人类研究中进一步探讨。